The Role of Activated Protein C Resistance in the Pathogenesis of Venous Thrombosis
- 1 August 1998
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 316 (2) , 120-128
- https://doi.org/10.1097/00000441-199808000-00007
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Activated protein C resistance and adverse pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1997
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- Resistance to activated protein C in healthy women taking oral contraceptivesBritish Journal of Haematology, 1995
- Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.Journal of Medical Genetics, 1995
- Ischemic Stroke in Young Patients With Activated Protein C ResistanceStroke, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Resistance to activated protein C is reduced in women using oral contraceptivesBlood Coagulation & Fibrinolysis, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Natural history of pulmonary embolismProgress in Cardiovascular Diseases, 1975